Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phosphoprotein Phosphatases | 12 | 2019 | 346 | 3.130 |
Why?
|
DNA Repair | 23 | 2022 | 2033 | 2.900 |
Why?
|
MicroRNAs | 24 | 2021 | 3620 | 2.430 |
Why?
|
DNA Breaks, Double-Stranded | 14 | 2022 | 580 | 1.890 |
Why?
|
BRCA1 Protein | 8 | 2020 | 1044 | 1.480 |
Why?
|
DNA Damage | 21 | 2022 | 2432 | 1.460 |
Why?
|
G1 Phase | 5 | 2019 | 418 | 1.380 |
Why?
|
Genomic Instability | 6 | 2018 | 688 | 1.220 |
Why?
|
DNA | 13 | 2022 | 7088 | 1.130 |
Why?
|
Radiation Tolerance | 5 | 2018 | 508 | 1.070 |
Why?
|
Histones | 9 | 2021 | 2550 | 0.990 |
Why?
|
Ovarian Neoplasms | 12 | 2021 | 4748 | 0.910 |
Why?
|
Granzymes | 6 | 2009 | 278 | 0.830 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2019 | 111 | 0.720 |
Why?
|
Cytoplasmic Dyneins | 1 | 2018 | 27 | 0.700 |
Why?
|
RNA-Binding Proteins | 5 | 2021 | 1885 | 0.690 |
Why?
|
Cell Line, Tumor | 22 | 2021 | 16729 | 0.610 |
Why?
|
Down-Regulation | 6 | 2016 | 3069 | 0.610 |
Why?
|
Serum | 1 | 2017 | 216 | 0.590 |
Why?
|
Protein Processing, Post-Translational | 4 | 2020 | 2010 | 0.580 |
Why?
|
Phosphorylation | 15 | 2020 | 8654 | 0.560 |
Why?
|
DNA Replication | 7 | 2022 | 1419 | 0.520 |
Why?
|
Genes, BRCA1 | 1 | 2018 | 759 | 0.520 |
Why?
|
Whole-Body Irradiation | 1 | 2015 | 451 | 0.510 |
Why?
|
Cisplatin | 2 | 2018 | 1645 | 0.510 |
Why?
|
Replication Protein A | 2 | 2014 | 65 | 0.510 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 429 | 0.500 |
Why?
|
Cell Lineage | 2 | 2021 | 2595 | 0.470 |
Why?
|
Conserved Sequence | 1 | 2017 | 1236 | 0.470 |
Why?
|
DNA Breaks | 1 | 2013 | 49 | 0.470 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2976 | 0.460 |
Why?
|
Radiation Injuries | 2 | 2018 | 1223 | 0.460 |
Why?
|
HeLa Cells | 9 | 2019 | 3212 | 0.460 |
Why?
|
RNA Interference | 9 | 2019 | 2983 | 0.450 |
Why?
|
Lysine | 1 | 2017 | 1029 | 0.450 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5191 | 0.440 |
Why?
|
Glioblastoma | 3 | 2016 | 3345 | 0.440 |
Why?
|
Exodeoxyribonucleases | 3 | 2007 | 182 | 0.410 |
Why?
|
Transforming Growth Factor beta | 2 | 2016 | 1974 | 0.410 |
Why?
|
Cystadenocarcinoma, Serous | 3 | 2021 | 468 | 0.410 |
Why?
|
Phthalazines | 3 | 2021 | 357 | 0.410 |
Why?
|
Phosphoproteins | 5 | 2020 | 2537 | 0.400 |
Why?
|
Carrier Proteins | 3 | 2021 | 5098 | 0.380 |
Why?
|
Lymphocytes | 3 | 2014 | 2734 | 0.370 |
Why?
|
RNA, Untranslated | 1 | 2013 | 448 | 0.360 |
Why?
|
Protein Binding | 8 | 2021 | 9559 | 0.350 |
Why?
|
Cell Cycle Proteins | 7 | 2022 | 3483 | 0.340 |
Why?
|
RNA, Small Interfering | 9 | 2019 | 3571 | 0.340 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1939 | 0.330 |
Why?
|
DNA Topoisomerases, Type II | 2 | 2022 | 116 | 0.320 |
Why?
|
Cell Death | 3 | 2009 | 1722 | 0.310 |
Why?
|
Apoptosis | 7 | 2020 | 9962 | 0.310 |
Why?
|
Blood Cells | 1 | 2009 | 318 | 0.310 |
Why?
|
Signal Transduction | 10 | 2020 | 23721 | 0.310 |
Why?
|
Nucleoside-Diphosphate Kinase | 1 | 2006 | 15 | 0.310 |
Why?
|
Cell Cycle | 6 | 2019 | 2987 | 0.300 |
Why?
|
Carcinoma | 1 | 2018 | 2320 | 0.300 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13620 | 0.290 |
Why?
|
Mitosis | 3 | 2019 | 1247 | 0.280 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2019 | 672 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 374 | 0.270 |
Why?
|
BRCA2 Protein | 4 | 2018 | 702 | 0.270 |
Why?
|
Serine Endopeptidases | 2 | 2006 | 1078 | 0.250 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2021 | 2943 | 0.250 |
Why?
|
Poly(ADP-ribose) Polymerases | 4 | 2014 | 425 | 0.250 |
Why?
|
S Phase | 2 | 2022 | 432 | 0.250 |
Why?
|
Telomere-Binding Proteins | 3 | 2020 | 96 | 0.240 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2008 | 1487 | 0.240 |
Why?
|
Multiprotein Complexes | 3 | 2014 | 1162 | 0.240 |
Why?
|
Genes, Immunoglobulin | 1 | 2004 | 286 | 0.240 |
Why?
|
Repressor Proteins | 2 | 2012 | 3064 | 0.240 |
Why?
|
Platinum | 3 | 2020 | 218 | 0.230 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2007 | 651 | 0.230 |
Why?
|
Binding Sites | 4 | 2021 | 6212 | 0.220 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3393 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2020 | 8561 | 0.220 |
Why?
|
Animals | 30 | 2022 | 169277 | 0.210 |
Why?
|
Humans | 69 | 2022 | 715636 | 0.210 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2018 | 509 | 0.210 |
Why?
|
Feedback, Physiological | 1 | 2004 | 476 | 0.210 |
Why?
|
Cell Line | 10 | 2020 | 16574 | 0.210 |
Why?
|
Antigens, Nuclear | 2 | 2016 | 203 | 0.200 |
Why?
|
Piperazines | 2 | 2014 | 2527 | 0.200 |
Why?
|
Neoplasms, Bone Tissue | 1 | 2020 | 7 | 0.200 |
Why?
|
Mice | 19 | 2022 | 80320 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11233 | 0.200 |
Why?
|
K562 Cells | 4 | 2010 | 626 | 0.190 |
Why?
|
Mutation | 12 | 2021 | 29270 | 0.190 |
Why?
|
Pyrazines | 3 | 2021 | 1246 | 0.190 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2019 | 17 | 0.190 |
Why?
|
Deoxycytidine | 2 | 2021 | 827 | 0.190 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2020 | 71 | 0.190 |
Why?
|
Pyrimidines | 3 | 2022 | 2929 | 0.180 |
Why?
|
Lim Kinases | 1 | 2019 | 15 | 0.180 |
Why?
|
G-Quadruplexes | 1 | 2020 | 77 | 0.180 |
Why?
|
Phosphoserine | 1 | 2019 | 220 | 0.180 |
Why?
|
Spodoptera | 2 | 2010 | 156 | 0.180 |
Why?
|
Brain Neoplasms | 3 | 2018 | 8801 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 4 | 2014 | 2881 | 0.170 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2018 | 39 | 0.170 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9498 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2018 | 90 | 0.160 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2018 | 102 | 0.160 |
Why?
|
DNA-Binding Proteins | 6 | 2016 | 9741 | 0.160 |
Why?
|
Benzoquinones | 2 | 2014 | 207 | 0.150 |
Why?
|
Chromatin | 5 | 2014 | 2683 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 206 | 0.150 |
Why?
|
Cell Division | 3 | 2012 | 4694 | 0.150 |
Why?
|
Oligonucleotides, Antisense | 2 | 2016 | 436 | 0.150 |
Why?
|
Cell Differentiation | 4 | 2010 | 11665 | 0.150 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2007 | 79 | 0.140 |
Why?
|
Oncogenes | 2 | 2021 | 1246 | 0.140 |
Why?
|
Glioma | 2 | 2022 | 3305 | 0.140 |
Why?
|
G2 Phase | 2 | 2014 | 147 | 0.140 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 18601 | 0.140 |
Why?
|
Protein Phosphatase 2 | 2 | 2008 | 224 | 0.140 |
Why?
|
Lactams, Macrocyclic | 2 | 2014 | 321 | 0.140 |
Why?
|
Protein Subunits | 2 | 2010 | 1000 | 0.140 |
Why?
|
Protein Transport | 2 | 2014 | 2054 | 0.140 |
Why?
|
Receptors, Antigen | 2 | 2005 | 53 | 0.140 |
Why?
|
RNA, Messenger | 7 | 2014 | 13205 | 0.130 |
Why?
|
HEK293 Cells | 3 | 2019 | 4267 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2012 | 987 | 0.130 |
Why?
|
Base Sequence | 3 | 2016 | 13180 | 0.130 |
Why?
|
Gene Expression Regulation | 6 | 2017 | 12299 | 0.130 |
Why?
|
Methylation | 1 | 2017 | 1097 | 0.130 |
Why?
|
Comet Assay | 2 | 2012 | 79 | 0.120 |
Why?
|
Telomere | 1 | 2019 | 844 | 0.120 |
Why?
|
Rad51 Recombinase | 2 | 2013 | 184 | 0.120 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 207 | 0.120 |
Why?
|
3' Untranslated Regions | 3 | 2011 | 513 | 0.120 |
Why?
|
Salvage Therapy | 1 | 2020 | 1307 | 0.120 |
Why?
|
Histone Deacetylases | 1 | 2018 | 750 | 0.120 |
Why?
|
Perforin | 3 | 2008 | 171 | 0.120 |
Why?
|
Nuclear Proteins | 5 | 2020 | 5939 | 0.120 |
Why?
|
Substrate Specificity | 2 | 2008 | 1828 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 790 | 0.110 |
Why?
|
Immunity, Innate | 1 | 2005 | 2941 | 0.110 |
Why?
|
Alleles | 1 | 2004 | 7097 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 356 | 0.110 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2012 | 30 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1479 | 0.110 |
Why?
|
Gene Silencing | 3 | 2008 | 1602 | 0.110 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1807 | 0.110 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 675 | 0.110 |
Why?
|
Cell Physiological Phenomena | 1 | 2013 | 153 | 0.110 |
Why?
|
Chromosome Breakage | 1 | 2012 | 171 | 0.110 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 275 | 0.100 |
Why?
|
Gene Library | 1 | 2014 | 1086 | 0.100 |
Why?
|
Sequence Alignment | 1 | 2016 | 2289 | 0.100 |
Why?
|
Female | 18 | 2021 | 377052 | 0.100 |
Why?
|
DNA-Activated Protein Kinase | 2 | 2012 | 116 | 0.100 |
Why?
|
Immunoprecipitation | 2 | 2010 | 937 | 0.100 |
Why?
|
Macaca mulatta | 1 | 2017 | 2431 | 0.100 |
Why?
|
Recombination, Genetic | 3 | 2012 | 1692 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1044 | 0.100 |
Why?
|
Pyrazoles | 1 | 2020 | 1957 | 0.100 |
Why?
|
E2F2 Transcription Factor | 1 | 2009 | 40 | 0.090 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2009 | 94 | 0.090 |
Why?
|
Enzyme Inhibitors | 4 | 2014 | 3895 | 0.090 |
Why?
|
Isoxazoles | 2 | 2021 | 217 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 2646 | 0.090 |
Why?
|
Genes, cdc | 1 | 2009 | 125 | 0.090 |
Why?
|
NF-kappa B | 1 | 2018 | 2553 | 0.090 |
Why?
|
Hematopoietic System | 1 | 2009 | 116 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 22648 | 0.090 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 14171 | 0.090 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 186 | 0.090 |
Why?
|
Radiotherapy | 1 | 2016 | 1612 | 0.090 |
Why?
|
Aneuploidy | 1 | 2012 | 479 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 712 | 0.090 |
Why?
|
Cell Proliferation | 6 | 2020 | 10603 | 0.090 |
Why?
|
Transcription Factors | 3 | 2020 | 11955 | 0.090 |
Why?
|
ras Proteins | 1 | 2014 | 1101 | 0.080 |
Why?
|
Endopeptidases | 1 | 2012 | 779 | 0.080 |
Why?
|
Baculoviridae | 1 | 2008 | 118 | 0.080 |
Why?
|
Bleomycin | 1 | 2009 | 504 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5406 | 0.080 |
Why?
|
Gamma Rays | 1 | 2009 | 327 | 0.080 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 58 | 0.080 |
Why?
|
Fibroblasts | 4 | 2019 | 4228 | 0.080 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2007 | 93 | 0.080 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1985 | 0.080 |
Why?
|
Subcellular Fractions | 1 | 2008 | 564 | 0.080 |
Why?
|
Catalytic Domain | 1 | 2010 | 714 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3569 | 0.080 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2006 | 20 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2009 | 474 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 4907 | 0.080 |
Why?
|
Antigens, Surface | 1 | 2011 | 1842 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2017 | 2542 | 0.070 |
Why?
|
Models, Biological | 3 | 2012 | 9815 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2020 | 407 | 0.070 |
Why?
|
Protein Structure, Tertiary | 5 | 2014 | 3964 | 0.070 |
Why?
|
African Americans | 1 | 2021 | 4991 | 0.070 |
Why?
|
Up-Regulation | 2 | 2021 | 4305 | 0.070 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 774 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 20514 | 0.070 |
Why?
|
Genes, myc | 2 | 2020 | 401 | 0.070 |
Why?
|
Helminths | 1 | 2005 | 27 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4264 | 0.070 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2021 | 454 | 0.070 |
Why?
|
Herpes Genitalis | 1 | 2005 | 134 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 7014 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2016 | 12530 | 0.070 |
Why?
|
Doxorubicin | 1 | 2011 | 2216 | 0.070 |
Why?
|
Herpesvirus 2, Human | 1 | 2005 | 181 | 0.060 |
Why?
|
Interferons | 3 | 2020 | 677 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2020 | 10598 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2973 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2446 | 0.060 |
Why?
|
Mutation, Missense | 3 | 2009 | 2515 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 144 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3526 | 0.060 |
Why?
|
RNA Editing | 1 | 2005 | 156 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10513 | 0.060 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2018 | 385 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2008 | 6806 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 809 | 0.060 |
Why?
|
Cytidine Deaminase | 1 | 2005 | 237 | 0.060 |
Why?
|
Immunoglobulin Variable Region | 1 | 2004 | 419 | 0.060 |
Why?
|
Adenosine Deaminase | 1 | 2005 | 242 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 702 | 0.060 |
Why?
|
Telomerase | 2 | 2019 | 734 | 0.060 |
Why?
|
Morpholines | 2 | 2018 | 571 | 0.060 |
Why?
|
Uridine | 1 | 2022 | 143 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14887 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6654 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2012 | 1510 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 8892 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1103 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15184 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 97 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4642 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2016 | 6480 | 0.050 |
Why?
|
Genome | 2 | 2019 | 1752 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2807 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1632 | 0.050 |
Why?
|
Mammals | 1 | 2005 | 934 | 0.050 |
Why?
|
Rats | 3 | 2019 | 24802 | 0.050 |
Why?
|
Gene Rearrangement | 1 | 2005 | 1199 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2014 | 20060 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1820 | 0.050 |
Why?
|
Cell Survival | 1 | 2010 | 6032 | 0.050 |
Why?
|
Guanine | 1 | 2020 | 280 | 0.040 |
Why?
|
Camptothecin | 2 | 2014 | 549 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 282 | 0.040 |
Why?
|
Virus Diseases | 1 | 2005 | 698 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19528 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1832 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11138 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 291 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2020 | 1800 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 2018 | 146 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2019 | 914 | 0.040 |
Why?
|
Aged | 6 | 2021 | 162383 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 409 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1104 | 0.040 |
Why?
|
Primates | 1 | 2019 | 513 | 0.040 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2007 | 134 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 995 | 0.040 |
Why?
|
Middle Aged | 6 | 2021 | 214618 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4286 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 19905 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 1966 | 0.030 |
Why?
|
Escherichia coli | 1 | 2008 | 4269 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2918 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1078 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 999 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2012 | 4978 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 547 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2018 | 1778 | 0.030 |
Why?
|
Cyclin B1 | 1 | 2014 | 52 | 0.030 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 116 | 0.030 |
Why?
|
Male | 6 | 2020 | 350156 | 0.030 |
Why?
|
Protein Engineering | 1 | 2018 | 552 | 0.030 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2014 | 64 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2298 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 3427 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2014 | 187 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 825 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2005 | 2868 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2014 | 117 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58288 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 940 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5371 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2212 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 1982 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 13210 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 6003 | 0.030 |
Why?
|
Hydroxyurea | 1 | 2014 | 290 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1698 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2014 | 335 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 165 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7950 | 0.030 |
Why?
|
Exosomes | 1 | 2016 | 402 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1580 | 0.030 |
Why?
|
Heterochromatin | 1 | 2014 | 303 | 0.030 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2011 | 52 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 554 | 0.030 |
Why?
|
DNA Fragmentation | 1 | 2012 | 249 | 0.030 |
Why?
|
Genetic Markers | 1 | 2018 | 2684 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2004 | 9848 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3802 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2012 | 403 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2014 | 879 | 0.030 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 283 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2461 | 0.030 |
Why?
|
Carboplatin | 1 | 2014 | 802 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 720 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2012 | 228 | 0.020 |
Why?
|
Macrophages | 2 | 2020 | 5747 | 0.020 |
Why?
|
Radiometry | 1 | 2016 | 812 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 526 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1123 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1770 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2021 | 1730 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 29 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6500 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6499 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1593 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 1916 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2129 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 380 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 5070 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2009 | 369 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2012 | 433 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3124 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 876 | 0.020 |
Why?
|
Staurosporine | 1 | 2009 | 254 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39334 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3050 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5465 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3738 | 0.020 |
Why?
|
Models, Chemical | 1 | 2009 | 634 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 674 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1407 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2823 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1256 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2007 | 189 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4468 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40042 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6123 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 948 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2005 | 143 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4889 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 6091 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3631 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3632 | 0.020 |
Why?
|
Megakaryocytes | 1 | 2009 | 533 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2007 | 395 | 0.020 |
Why?
|
Proteomics | 1 | 2018 | 3256 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 907 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2007 | 3818 | 0.020 |
Why?
|
Receptors, HIV | 1 | 2005 | 162 | 0.020 |
Why?
|
Genes, Essential | 1 | 2005 | 185 | 0.020 |
Why?
|
Endosomes | 1 | 2007 | 528 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 28987 | 0.020 |
Why?
|
Genes, Viral | 1 | 2005 | 775 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7901 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2134 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13219 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21802 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3681 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 6095 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2555 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1201 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1840 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6080 | 0.010 |
Why?
|
Liposomes | 1 | 2005 | 744 | 0.010 |
Why?
|
Arginine | 1 | 2006 | 954 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16308 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2006 | 785 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 578 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 556 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2984 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2184 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5392 | 0.010 |
Why?
|
Vagina | 1 | 2005 | 778 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 62037 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2793 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3719 | 0.010 |
Why?
|
Erythrocytes | 1 | 2009 | 2411 | 0.010 |
Why?
|
Adult | 3 | 2020 | 212228 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13765 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4708 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1896 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1960 | 0.010 |
Why?
|
Virus Replication | 1 | 2005 | 2565 | 0.010 |
Why?
|
Lung | 1 | 2016 | 9733 | 0.010 |
Why?
|
Antibodies | 1 | 2005 | 2428 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2006 | 2993 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3845 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6633 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2007 | 17399 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11665 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56137 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 12931 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85064 | 0.010 |
Why?
|
Child | 1 | 2018 | 74418 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 6899 | 0.000 |
Why?
|
Inflammation | 1 | 2005 | 10091 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40892 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 70927 | 0.000 |
Why?
|